Back to results
US 2025/0367338 A1Published application
Hemostatic sponge
AssigneesBaxter International Inc., Baxter Healthcare S.A.
InventorsHans Christian Hedrich, Joris Hoefinghoff, Woonza M. Rhee, Atsushi Edward Osawa
Life of this patent
Estimating the term…
Abstract
The present invention provides a hemostatic composite sponge comprising oxidized cellulose and an essentially gelatin-free bioadhesive material stably associated with said sponge and present in an organized pattern on said sponge.
Claims8
-26. (canceled)
A method for treating an injury in a patient, the method comprising:
- providing a hemostatic porous composite sponge, wherein the hemostatic porous
- composite sponge comprising a matrix of biomaterial and a bioadhesive material stably associated with at least one surface of the hemostatic porous composite sponge, the bioadhesive material is present in a range of 2 to 50 mg/cm2 of the biomaterial
- administering the hemostatic porous composite sponge to a site of the injury;
- and
- maintaining the hemostatic porous composite sponge to the site of the injury for a pharmaceutically sufficient amount of time so that the injury is treated.
2 more elements
Dependencies are inferred from the claim text.